Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natália Bernardi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Applied Toxicology : JAT|August 30, 2023
The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limitsNatália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, et al.
Frontiers in Bioengineering and Biotechnology|June 28, 2019
Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its ImmunotoxicityJessica Da Silva, Sandra Jesus, Natália Bernardi, et al.
PPAR Research|June 1, 2018
Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False PositivesNatália Bernardi Videira, Fernanda Aparecida Heleno Batista, Artur Torres Cordeiro, et al.
Frontiers in Endocrinology|February 17, 2018
Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition PropertiesHelder Veras Ribeiro Filho, Natália Bernardi Videira, Aline Villanova Bridi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Applied Toxicology : JAT|August 30, 2023
The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limitsNatália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, et al.
Frontiers in Bioengineering and Biotechnology|June 28, 2019
Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its ImmunotoxicityJessica Da Silva, Sandra Jesus, Natália Bernardi, et al.
PPAR Research|June 1, 2018
Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False PositivesNatália Bernardi Videira, Fernanda Aparecida Heleno Batista, Artur Torres Cordeiro, et al.
Frontiers in Endocrinology|February 17, 2018
Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition PropertiesHelder Veras Ribeiro Filho, Natália Bernardi Videira, Aline Villanova Bridi, et al.
Pageof 1